.png){kind=icon}
OECD 452/OCSPP 870.4100: Chronic toxicity studies
Chronic (26-52 wk)
Toxicity studies: Chronic
Validation:GLP
Models:Mouse,老鼠,Canine,Mini-pig,NHP
Disease:Asthma & Allergy,Autoimmune & Inflammatory,Cardiology,CNS,Dermatology,Gastroenterology,General Medicine,Hematology,Infectious Disease,Metabolic Endocrine,Musculoskeletal,NASH,肾脏学,Oncology,Ophthalmology,Pediatrics,Pulmonary Respiratory,Rare Disease,Renal Hepatic,Reproductive Health,Rheumatology,Urology
The chronic toxicity study provides information on possible health hazards likely to arise from repeated exposure over a considerable part of test species' lifespan.
Studies provide data about toxic effects of a substance, indicate target organs and the possibility of accumulation. They can also provide estimates of no-observed-adverse effect levels to help establish safety criteria for human exposure.
Test duration ranges from 26 to 52 weeks, depending on test species. The majority of chronic toxicity studies are carried out in rodent species, but NHP are also used.
The three main routes of administration used in chronic toxicity studies are oral, dermal and inhaled. The choice of the route depends on the physical and chemical characteristics of the test chemical and the predominant route of exposure in humans.
About our nonclinical animal research models: We provide the utmost care for our research animals and actively pursue advances in animal welfare. As well as ensuring the highest scientific, ethical and regulatory standards, selection of appropriate animal research models for development research is critical to developing safe and effective treatments, devices and products that protect and save lives. Just as we have ethical committee oversight for human trials, we have ethical committees overseeing all aspects of our global animal care and use programs. All of our core, nonclinical facilities are accredited by AAALAC.Learn more about our commitment to replacing, reusing and refining nonclinical research models.